Home › Funds › Crews Bank & Trust › GRDN
Crews Bank & Trust position in GRDN
GUARDIAN PHARMACY SVCS INC · Consumer Staples
Crews Bank & Trust reported holding 101,127 shares of GRDN (GUARDIAN PHARMACY SVCS INC) in its Q3 2026 13F filing — a position valued at US$4.1M, representing 0.54% of its reported portfolio and ranking #34 among its reported holdings. Crews Bank & Trust has disclosed GRDN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Crews Bank & Trust's GRDN position evolved
Crews Bank & Trust first disclosed a stake in GRDN in Q2 2026 at 101,127 shares (US$4.2M). Across 2 filings, Crews Bank & Trust held the position steady without any share-count change. The most recent filing (Q3 2026) shows 101,127 shares valued at US$4.1M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 101.13K | $4.23M | New |
| Q3 2026 | 101.13K | $4.12M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GRDN and 13F data
GRDN (GUARDIAN PHARMACY SVCS INC) is a Consumer Staples company. 53 other funds we track also report a position in GRDN — the largest reported positions include Valiant Capital Management, L.P. (US$32.8M), BOONE CAPITAL MANAGEMENT LLC (US$29.6M), Aristotle Capital Boston, LLC (US$13.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GRDN
- Valiant Capital Management, L.P. 803.40K sh · $32.76M · Q3 2026
- BOONE CAPITAL MANAGEMENT LLC 725.06K sh · $29.57M · Q3 2026
- Aristotle Capital Boston, LLC 326.50K sh · $13.31M · Q3 2026
- Lisanti Capital Growth, LLC 147.44K sh · $6.01M · Q3 2026
More on Crews Bank & Trust
FAQ
How long has Crews Bank & Trust held GRDN?
Crews Bank & Trust has disclosed GRDN holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Crews Bank & Trust's current position in GRDN?
As of Q3 2026, Crews Bank & Trust holds 101.13K shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $4.12M, representing 0.54% of its reported portfolio and ranking #34.
Has Crews Bank & Trust been buying or selling GRDN?
In the latest 13F filing (Q3 2026), Crews Bank & Trust held unchanged its position in GRDN.
Which other funds hold GRDN?
Other major institutional holders of GRDN include Valiant Capital Management, L.P., BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.